CN106317078A - 一种采用超分子机理制成的头孢曲松钠化合物及其制剂 - Google Patents
一种采用超分子机理制成的头孢曲松钠化合物及其制剂 Download PDFInfo
- Publication number
- CN106317078A CN106317078A CN201610670415.9A CN201610670415A CN106317078A CN 106317078 A CN106317078 A CN 106317078A CN 201610670415 A CN201610670415 A CN 201610670415A CN 106317078 A CN106317078 A CN 106317078A
- Authority
- CN
- China
- Prior art keywords
- ceftriaxone sodium
- preparation
- ceftriaxone
- acid
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CO*=C([C@]1*C(N)=SC1)C(*)=C Chemical compound CO*=C([C@]1*C(N)=SC1)C(*)=C 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/12—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
编号 | d值 | 2θ(°) | I/I0% |
1 | 7.71 | 11.48 | 36.66 |
2 | 6.81 | 13.00 | 32.12 |
3 | 4.75 | 18.66 | 73.97 |
4 | 4.67 | 19.00 | 86.76 |
5 | 4.57 | 19.44 | 100.00 |
6 | 4.47 | 19.84 | 91.80 |
7 | 4.30 | 20.67 | 39.74 |
8 | 3.77 | 23.58 | 22.39 |
9 | 3.62 | 24.61 | 53.22 |
10 | 3.56 | 25.04 | 38.21 |
实施例 | 有关物质 |
实施例1 | 0.12% |
对比例1 | 0.49% |
对比例2 | 0.41% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610670415.9A CN106317078A (zh) | 2016-08-15 | 2016-08-15 | 一种采用超分子机理制成的头孢曲松钠化合物及其制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610670415.9A CN106317078A (zh) | 2016-08-15 | 2016-08-15 | 一种采用超分子机理制成的头孢曲松钠化合物及其制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106317078A true CN106317078A (zh) | 2017-01-11 |
Family
ID=57740542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610670415.9A Pending CN106317078A (zh) | 2016-08-15 | 2016-08-15 | 一种采用超分子机理制成的头孢曲松钠化合物及其制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106317078A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109134503A (zh) * | 2017-06-14 | 2019-01-04 | 王明 | 一种四水头孢曲松钠化合物 |
CN110452255A (zh) * | 2019-09-05 | 2019-11-15 | 上海龙翔生物医药开发有限公司 | 头孢曲松钠的晶型及其制备方法 |
CN113105478A (zh) * | 2021-03-23 | 2021-07-13 | 广东金城金素制药有限公司 | 一水头孢曲松钠化合物及其晶型、制备方法和制剂 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245735B1 (en) * | 1996-07-29 | 2001-06-12 | The Brigham And Women's Hospital, Inc. | Methods and products for treating pseudomonas infection |
CN102875574A (zh) * | 2012-08-31 | 2013-01-16 | 石药集团中诺药业(石家庄)有限公司 | 头孢曲松钠晶型及其制备方法 |
CN102993215A (zh) * | 2012-05-16 | 2013-03-27 | 悦康药业集团有限公司 | 头孢曲松钠晶体的制备方法及头孢曲松钠水溶液浊度的评价方法 |
CN103690952A (zh) * | 2013-11-27 | 2014-04-02 | 广西大学 | 治疗畜禽大肠杆菌感染疾病的复方药物 |
-
2016
- 2016-08-15 CN CN201610670415.9A patent/CN106317078A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245735B1 (en) * | 1996-07-29 | 2001-06-12 | The Brigham And Women's Hospital, Inc. | Methods and products for treating pseudomonas infection |
CN102993215A (zh) * | 2012-05-16 | 2013-03-27 | 悦康药业集团有限公司 | 头孢曲松钠晶体的制备方法及头孢曲松钠水溶液浊度的评价方法 |
CN102875574A (zh) * | 2012-08-31 | 2013-01-16 | 石药集团中诺药业(石家庄)有限公司 | 头孢曲松钠晶型及其制备方法 |
CN103690952A (zh) * | 2013-11-27 | 2014-04-02 | 广西大学 | 治疗畜禽大肠杆菌感染疾病的复方药物 |
Non-Patent Citations (3)
Title |
---|
MIO TANGE等,: ""Comparison of the Dissolution Rate of Ceftriaxone Sodium Preparations for Injection"", 《CHEM. PHARM. BULL.》 * |
李惠芬等,: ""头孢曲松钠结晶工艺研究"", 《河北化工》 * |
汪东海等,: ""头孢曲松钠精制方法的改进"", 《山东化工》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109134503A (zh) * | 2017-06-14 | 2019-01-04 | 王明 | 一种四水头孢曲松钠化合物 |
CN109134503B (zh) * | 2017-06-14 | 2020-06-19 | 陕西顿斯制药有限公司 | 一种四水头孢曲松钠化合物 |
CN110452255A (zh) * | 2019-09-05 | 2019-11-15 | 上海龙翔生物医药开发有限公司 | 头孢曲松钠的晶型及其制备方法 |
CN113105478A (zh) * | 2021-03-23 | 2021-07-13 | 广东金城金素制药有限公司 | 一水头孢曲松钠化合物及其晶型、制备方法和制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106317078A (zh) | 一种采用超分子机理制成的头孢曲松钠化合物及其制剂 | |
AU2016200570B2 (en) | Solid Forms of Ceftolozane | |
CN102659818B (zh) | 一种盐酸头孢替安晶体化合物及其制备方法及含该化合物的药物组合物 | |
US11952396B1 (en) | Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use | |
CN104771372A (zh) | 一种注射用头孢呋辛钠粉针制剂 | |
CN103012434B (zh) | 一种头孢硫脒化合物晶体其制备方法及其药物组合物 | |
CN103524532B (zh) | 一种头孢唑肟钠化合物晶型、制备方法及其药物制剂 | |
CN110372727B (zh) | 头孢妥仑酸δ3异构体及头孢妥仑匹酯δ3异构体的制备方法 | |
CN106279208A (zh) | 一种利用流体力学原理制备的头孢噻肟钠化合物及其制剂 | |
CN109134502A (zh) | 一种1/2水头孢呋辛钠化合物 | |
CN109096304A (zh) | 一种3/4水头孢呋辛钠化合物 | |
CN106317080A (zh) | 一种采用耦合结晶技术制备的头孢他啶化合物及其制剂 | |
CN104644637A (zh) | 一种注射用哌拉西林钠他唑巴坦钠制剂及其制备方法 | |
CN105440054B (zh) | 一种制备头孢硫脒的工艺 | |
CN109796404B (zh) | 一种甲磺酸恩诺沙星晶体及其制备方法和用途 | |
CN109134500A (zh) | 一种1/2水头孢拉定化合物 | |
CN109912625B (zh) | 一种降低头孢他啶杂质h的工艺方法 | |
WO2017140073A1 (zh) | 一种采用粒子过程晶体产品分子组装与形态优化技术的头孢硫脒新晶型化合物及制剂 | |
CN105106139A (zh) | 一种治疗泌尿外科类疾病的药物他达拉非组合物颗粒剂 | |
CN109096309B (zh) | 一种43/4水头孢他啶化合物及其药物组合物 | |
CN105055420A (zh) | 一种治疗细菌感染的药物头孢孟多酯钠组合物 | |
CN109160924A (zh) | 一种二水盐酸头孢替安化合物及其药物组合物制剂 | |
CN107868117B (zh) | 司坦唑醇糖精盐及其制备方法和应用 | |
CN109111467A (zh) | 一种51/4水头孢他啶化合物及其药物组合物制剂 | |
CN117886783A (zh) | 一种紫杉烷化合物的水合物晶型c及其制备方法、用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181115 Address after: 571900 Hainan Province Haikou Old Town High-tech Industrial Demonstration Zone Hainan Eco-Software Park A-5 Building 2-storey Eastern District Applicant after: Hainan Li Cheng Pharmaceutical Sales Co., Ltd. Applicant after: Shaanxi fotboll Pharmaceutical Co. Ltd. Address before: 710399 First Stage Construction Zone of Standardized Workshop of Fengjing Industrial Park, Xi'an City, Shaanxi Province Applicant before: Shaanxi fotboll Pharmaceutical Co. Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170111 |
|
RJ01 | Rejection of invention patent application after publication |